SMTL ID : 7y1g.1 (1 other biounit)

Crystal structure of human PRKACA complexed with DS01080522

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x I5G: 1-chloranyl-~{N}-[(~{S})-(3-chloranyl-4-cyano-phenyl)-[(2~{R},4~{S})-4-oxidanylpyrrolidin-2-yl]methyl]-7-methoxy-isoquinoline-6-carboxamide(Non-covalent)

I5G.1: 22 residues within 4Å: Chain A: L.50, G.51, T.52, G.53, S.54, F.55, G.56, R.57, V.58, A.71, K.73, V.105, M.121, E.122, Y.123, V.124, E.171, N.172, L.174, T.184, D.185, F.328 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.58, A:A.71, A:V.105, A:L.174 Hydrogen bonds: A:F.55, A:G.56, A:K.73, A:V.124, A:E.171, A:D.185

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Toyota, A. et al., Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model. Biochem.Biophys.Res.Commun. (2022)

Release Date

2022-09-28

Peptides

cAMP-dependent protein kinase catalytic subunit alpha: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cAMP-dependent protein kinase catalytic subunit alpha

Related Entries With Identical Sequence